To my knowledge, they haven't made any arguments. They just decided to strike it off. It's an outrage. Speaking as a diabetes specialist, I have several thousand people on this drug and there's nothing quite as good.
There are other flavours from other manufacturers. Novo Nordisk has Ozempic and Eli Lilly has Mounjaro. Other companies will be coming up with better drugs in the future. It's a competitive market. Prices will go down in Canada. Of course, if our procurement process could get better prices for the nation, as in Germany, then it would be a no-brainer.
